Respicardia, Inc. clinical trials
Acquired by Zoll Medical Corporation, 2021 · source ↗
The registry lists 8 studies whose lead sponsor is Respicardia, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 2, 2026.
Before and after it joined Zoll Medical Corporation
- First submitted before Respicardia, Inc. became part of Zoll Medical Corporation
- 8
- First submitted after Respicardia, Inc. became part of Zoll Medical Corporation
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Respicardia, Inc.8 studies
Something wrong with this grouping? Tell us on the Zoll Medical Corporation page.
Studies
Recruiting first, then most recently updated. Showing 8 of 8. All Zoll Medical Corporation studies →
- remedē System Therapy StudyActive, not recruitingNCT03884660
Sponsor listed in the registry: Respicardia, Inc. · First submitted before Respicardia, Inc. became part of Zoll Medical Corporation
- Janus Feasibility StudyCompletedNCT03985527Not applicable
Sponsor listed in the registry: Respicardia, Inc. · First submitted before Respicardia, Inc. became part of Zoll Medical Corporation
- Post Approval Study of the remedē SystemCompletedNCT03425188
Sponsor listed in the registry: Respicardia, Inc. · First submitted before Respicardia, Inc. became part of Zoll Medical Corporation
- Respicardia, Inc. Pivotal Trial of the remedē SystemCompletedNCT01816776Not applicable
Sponsor listed in the registry: Respicardia, Inc. · First submitted before Respicardia, Inc. became part of Zoll Medical Corporation
- Chronic Evaluation of Respicardia TherapyCompletedNCT01124370Phase 2
Sponsor listed in the registry: Respicardia, Inc. · First submitted before Respicardia, Inc. became part of Zoll Medical Corporation
- Prospective Evaluation of Heart Failure Patients With Central Sleep ApneaTerminatedNCT01414309
Sponsor listed in the registry: Respicardia, Inc. · First submitted before Respicardia, Inc. became part of Zoll Medical Corporation
- Feasibility Study to Determine the Effects of Phrenic Nerve Stimulation in Patients With Periodic BreathingCompletedNCT00909259Phase 1
Sponsor listed in the registry: Respicardia, Inc. · First submitted before Respicardia, Inc. became part of Zoll Medical Corporation
- Identification of the Pericardiophrenic Vein During Cardiac Device Implant Procedures to Prevent Extracardiac StimulationCompletedNCT01008670
Sponsor listed in the registry: Respicardia, Inc. · First submitted before Respicardia, Inc. became part of Zoll Medical Corporation